| Dr David Thomas Woody, OD | |
|
311 N 3rd St, Bardstown, KY 40004-1507 | |
| (502) 348-8584 | |
| (502) 348-4695 |
| Full Name | Dr David Thomas Woody |
|---|---|
| Gender | Male |
| Speciality | Optometry |
| Experience | 32 Years |
| Location | 311 N 3rd St, Bardstown, Kentucky |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1467583468 | NPI | - | NPPES |
| 000000049974 | Other | KY | UNICARE PROVIDER NUMBER |
| 000000049974 | Other | KY | ANTHEM PROVIDER NUMBER |
| 77012482 | Medicaid | KY | |
| 911296 | Other | KY | PASSPORT PROVIDER NUMBER |
| 410023108 | Other | KY | RAILROAD MEDICARE NUMBER |
| 4673505 | Other | KY | AETNA PROVIDER NUMBER |
| 11314 | Other | KY | UNITED HEALTH CARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | 1248DT (Kentucky) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Lisa Sloan Woody Od Psc Bardstown Eye Care | 1658315833 | 2 |
| Family First Vision Care Kentucky Llc | 3577975291 | 10 |
News Archive
The population based, 27 year longitudinal study, led by Dr Rachel Whitmer, Gerontological Epidemiologist at Kaiser Permanente Division of Research, Oakland California, involved 10,276 members of Kaiser Permanente medical care programme in California who underwent detailed health checks from 1964 to 1973 when they were aged 40-45 and who were still members of the health plan in 1994.
Visits to a gynaecologist or midwife are generally associated with different tests and/or prescriptions for contraceptives, but could offer so much more. Women, doctors and midwives are agreed that gynaecological visits presents great opportunities for dialogue about sexual health, reveals a thesis from the Sahlgrenska Academy at the University of Gothenburg, Sweden.
Momenta Pharmaceuticals, Inc., a biotechnology company specializing in the characterization and engineering of complex drugs, today announced that on August 25, 2010, the United States District Court for the District of Columbia denied sanofi-aventis U.S. LLC's request for a preliminary injunction directing the FDA to suspend and withdraw its approval of the Abbreviated New Drug Application (ANDA) filed by the Company's collaboration partner, Sandoz, for enoxaparin sodium injection USP, a generic version of Lovenox®. The decision is subject to appeal.
Deloitte Recap LLC (Recap) has launched "Development Optimizer," the third product in the Recap IQ Series by Deloitte. The series of biopharmaceutical business intelligence tools are part of a new subscription service tailored toward business development, corporate strategy, financial, clinical development, legal, academic and R&D professionals.
› Verified 2 days ago
| Provider Name | Ky Doctors Of Optometry Pllc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1700890001 PECOS PAC ID: 0941108732 Enrollment ID: O20031231000020 |
News Archive
The population based, 27 year longitudinal study, led by Dr Rachel Whitmer, Gerontological Epidemiologist at Kaiser Permanente Division of Research, Oakland California, involved 10,276 members of Kaiser Permanente medical care programme in California who underwent detailed health checks from 1964 to 1973 when they were aged 40-45 and who were still members of the health plan in 1994.
Visits to a gynaecologist or midwife are generally associated with different tests and/or prescriptions for contraceptives, but could offer so much more. Women, doctors and midwives are agreed that gynaecological visits presents great opportunities for dialogue about sexual health, reveals a thesis from the Sahlgrenska Academy at the University of Gothenburg, Sweden.
Momenta Pharmaceuticals, Inc., a biotechnology company specializing in the characterization and engineering of complex drugs, today announced that on August 25, 2010, the United States District Court for the District of Columbia denied sanofi-aventis U.S. LLC's request for a preliminary injunction directing the FDA to suspend and withdraw its approval of the Abbreviated New Drug Application (ANDA) filed by the Company's collaboration partner, Sandoz, for enoxaparin sodium injection USP, a generic version of Lovenox®. The decision is subject to appeal.
Deloitte Recap LLC (Recap) has launched "Development Optimizer," the third product in the Recap IQ Series by Deloitte. The series of biopharmaceutical business intelligence tools are part of a new subscription service tailored toward business development, corporate strategy, financial, clinical development, legal, academic and R&D professionals.
› Verified 2 days ago
| Provider Name | Lisa Sloan Woody Od Psc Bardstown Eye Care |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1639380793 PECOS PAC ID: 1658315833 Enrollment ID: O20050617000871 |
News Archive
The population based, 27 year longitudinal study, led by Dr Rachel Whitmer, Gerontological Epidemiologist at Kaiser Permanente Division of Research, Oakland California, involved 10,276 members of Kaiser Permanente medical care programme in California who underwent detailed health checks from 1964 to 1973 when they were aged 40-45 and who were still members of the health plan in 1994.
Visits to a gynaecologist or midwife are generally associated with different tests and/or prescriptions for contraceptives, but could offer so much more. Women, doctors and midwives are agreed that gynaecological visits presents great opportunities for dialogue about sexual health, reveals a thesis from the Sahlgrenska Academy at the University of Gothenburg, Sweden.
Momenta Pharmaceuticals, Inc., a biotechnology company specializing in the characterization and engineering of complex drugs, today announced that on August 25, 2010, the United States District Court for the District of Columbia denied sanofi-aventis U.S. LLC's request for a preliminary injunction directing the FDA to suspend and withdraw its approval of the Abbreviated New Drug Application (ANDA) filed by the Company's collaboration partner, Sandoz, for enoxaparin sodium injection USP, a generic version of Lovenox®. The decision is subject to appeal.
Deloitte Recap LLC (Recap) has launched "Development Optimizer," the third product in the Recap IQ Series by Deloitte. The series of biopharmaceutical business intelligence tools are part of a new subscription service tailored toward business development, corporate strategy, financial, clinical development, legal, academic and R&D professionals.
› Verified 2 days ago
| Provider Name | Family First Vision Care Kentucky Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1396396750 PECOS PAC ID: 3577975291 Enrollment ID: O20201221002707 |
News Archive
The population based, 27 year longitudinal study, led by Dr Rachel Whitmer, Gerontological Epidemiologist at Kaiser Permanente Division of Research, Oakland California, involved 10,276 members of Kaiser Permanente medical care programme in California who underwent detailed health checks from 1964 to 1973 when they were aged 40-45 and who were still members of the health plan in 1994.
Visits to a gynaecologist or midwife are generally associated with different tests and/or prescriptions for contraceptives, but could offer so much more. Women, doctors and midwives are agreed that gynaecological visits presents great opportunities for dialogue about sexual health, reveals a thesis from the Sahlgrenska Academy at the University of Gothenburg, Sweden.
Momenta Pharmaceuticals, Inc., a biotechnology company specializing in the characterization and engineering of complex drugs, today announced that on August 25, 2010, the United States District Court for the District of Columbia denied sanofi-aventis U.S. LLC's request for a preliminary injunction directing the FDA to suspend and withdraw its approval of the Abbreviated New Drug Application (ANDA) filed by the Company's collaboration partner, Sandoz, for enoxaparin sodium injection USP, a generic version of Lovenox®. The decision is subject to appeal.
Deloitte Recap LLC (Recap) has launched "Development Optimizer," the third product in the Recap IQ Series by Deloitte. The series of biopharmaceutical business intelligence tools are part of a new subscription service tailored toward business development, corporate strategy, financial, clinical development, legal, academic and R&D professionals.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr David Thomas Woody, OD 311 N 3rd St, Bardstown, KY 40004-1507 Ph: (502) 348-8584 | Dr David Thomas Woody, OD 311 N 3rd St, Bardstown, KY 40004-1507 Ph: (502) 348-8584 |
News Archive
The population based, 27 year longitudinal study, led by Dr Rachel Whitmer, Gerontological Epidemiologist at Kaiser Permanente Division of Research, Oakland California, involved 10,276 members of Kaiser Permanente medical care programme in California who underwent detailed health checks from 1964 to 1973 when they were aged 40-45 and who were still members of the health plan in 1994.
Visits to a gynaecologist or midwife are generally associated with different tests and/or prescriptions for contraceptives, but could offer so much more. Women, doctors and midwives are agreed that gynaecological visits presents great opportunities for dialogue about sexual health, reveals a thesis from the Sahlgrenska Academy at the University of Gothenburg, Sweden.
Momenta Pharmaceuticals, Inc., a biotechnology company specializing in the characterization and engineering of complex drugs, today announced that on August 25, 2010, the United States District Court for the District of Columbia denied sanofi-aventis U.S. LLC's request for a preliminary injunction directing the FDA to suspend and withdraw its approval of the Abbreviated New Drug Application (ANDA) filed by the Company's collaboration partner, Sandoz, for enoxaparin sodium injection USP, a generic version of Lovenox®. The decision is subject to appeal.
Deloitte Recap LLC (Recap) has launched "Development Optimizer," the third product in the Recap IQ Series by Deloitte. The series of biopharmaceutical business intelligence tools are part of a new subscription service tailored toward business development, corporate strategy, financial, clinical development, legal, academic and R&D professionals.
› Verified 2 days ago
Thomas G. Brelage, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 206 W John Fitch Ave, Bardstown, KY 40004 Phone: 502-348-1107 Fax: 502-348-0294 | |
Dr. Lisa Sloan Woody, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 311 N 3rd St, Bardstown, KY 40004 Phone: 502-348-8584 Fax: 502-348-4695 | |
Dr. Holly Renee Schat, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 115 S 5th St, Bardstown, KY 40004 Phone: 502-348-5125 Fax: 502-348-2485 | |
Dr. Leslie W. Cecil, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 115 S 5th St, Bardstown, KY 40004 Phone: 502-348-5125 Fax: 502-348-2485 | |
Dr. Meghan Gambrel, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 115 S 5th St, Bardstown, KY 40004 Phone: 502-348-5125 Fax: 502-348-2485 | |
Dr. Robert Lee Mcclellan, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 115 S 5th St, Bardstown, KY 40004 Phone: 502-348-5125 Fax: 502-348-2485 |